Federal Court finds glaucoma drug patent not obvious, declines approval for generic
The Federal Court has denied approval for a generic equivalent of a patented glaucoma medication, rejecting arguments that the patent on the medication, which was an improvement over a previous formulation,...To view the full article, register now.
Already a subscriber? Click here to view full article